Commerce Bank Alaunos Therapeutics, Inc. Transaction History

Commerce Bank

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$0.04 - $0.13 $880 - $2,860	-22,000 Reduced 4.79%	437,000 $30,000
Q4 2021 Feb 14, 2022	SELL	$1.09 - $1.89 $545 - $945	-500 Reduced 0.11%	459,000 $500,000
Q3 2021 Nov 09, 2021	BUY	$1.44 - $2.73 $720 - $1,365	500 Added 0.11%	459,500 $836,000
Q4 2020 Feb 09, 2021	SELL	$2.09 - $3.09 $6,384 - $9,439	-3,055 Reduced 0.66%	459,000 $1.16 Million
Q1 2020 May 08, 2020	BUY	$1.9 - $4.98 $109,354 - $286,623	57,555 Added 14.23%	462,055 $1.13 Million
Q4 2019 Feb 14, 2020	BUY	$3.95 - $5.35 $395,000 - $535,000	100,000 Added 32.84%	404,500 $1.91 Million
Q3 2017 Nov 07, 2017	BUY	$4.99 - $6.57 $1.52 Million - $2 Million	304,500	304,500 $1.87 Million

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $458M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Commerce Bank, based on Form 13F filings with the SEC.

Stay updated on Commerce Bank with notifications on news.